SBRI Healthcare projects save the NHS millions

SBRI projects have saved the NHS millions – and are expected to save billions more in the future

An independent review has highlighted how the NHS and other public sector organisations have saved £30m, thus achieving wider economic and social benefits, through eight SBRI Healthcare projects.

The NHS commissioned the PA Consulting report – entitled ‘SBRI Healthcare: a review of the benefits of the Small Business Research Initiative in healthcare’ – and it outlines how the projects delivered a £30m saving by July 2017, with recurring annual savings running at £19m.

These projects have also had the benefit of attracted £122m in private investment, delivered £6.4m in export sales and created 285 jobs.

The 8 high-impact projects that helped to deliver the saving include:

  • Isansys Lifecare, which supports automated patient observations and alerts through wearable sensors to support better care management and treatment
  • My mHealth, whose self-management telehealth system helps patients with lung diseases
  • 365 Response, which has developed an online marketplace for non-emergency patient transport

PA Consulting also looked at a further 14 projects to assess future economic impact. Early estimates show potential savings for the NHS could rise to between £350 and £480m in 2022, and £1.2 to £1.8bn in 2027.

In total, SBRI Healthcare funded 176 projects to a value of £73m from 2013 to July 2017.

Karen Livingstone, national director of SBRI Healthcare, said:

“SBRI Healthcare is helping to ensure the NHS embraces innovation that benefits patients, saves the NHS money and keeps the service in the vanguard of medical science and development.

“At a time of budgetary constraint, new thinking and innovative technology should not be seen as a threat to the NHS’s stability, but rather as a key stepping stone towards a successful future.”

Don’t forget to follow us on Twitter, or connect with us on LinkedIn!

Don’t forget to follow us on Twitter like us on Facebook or connect with us on LinkedIn!

Be the first to comment

Leave a Reply